WebNov 21, 2024 · In addition, a modified Harvard Breast Cosmesis Scale was used to assess patient-reported cosmesis . Results. Between December 2015 and November 2024, 76 women underwent wide local excision with negative margins and received 3 fraction PBS proton APBI. The median time from surgery to the initiation of radiotherapy was 44 days … WebThe measurements represent the nipple displacement and the asymmetry in breast dimensions and contour. Same photographs were scored subjectively by a …
Accelerated Partial Breast Irradiation Using Intensity …
WebThe grade 1 seroma rate at 3 months was 20%, which dropped to 8% at 12 months; no events required intervention. At 12 months, 91% of patients reported an overall quality of life score as ≥8 of 10, and patient-reported cosmesis was good or excellent in 95%. All patients are alive without relapse at the last follow-up. WebNov 11, 2011 · Background To report the clinical outcome after a Single Shot 3D-CRT PBI (SSPBI) in breast cancer patients after conservative surgery (ClinicalTrials.gov Identifier: NCT01316328). Methods A dose of 18Gy (in the first 4 patients) and 21Gy (in the remaining 60 patients) was prescribed in a single session and delivered to the index area (i.e. the … bookshelf speakers for sale south africa
Evaluation of Vectra® XT 3D Surface Imaging Technology in
WebThe prescription was 21.9 Gy (RBE 1.1) in 3 daily fractions to the post-operative tumor bed with a 1 cm expansion. Toxicities were collected using Common Terminology Criteria for Adverse Events (CTCAE) version 4.0, 10-point Linear Analog Scale Assessment, Patient-Reported Outcomes Version of the CTCAE, and the Harvard Breast Cosmesis Scale. WebAbbreviations: ASTRO = American Society for Radiation Oncology; BCTOS = Breast Cancer Treatment Outcomes Scale; BMI = body mass index; cm = centimeter; CQ = Contextual Question; CT = computed tomography; CTCAE = Common Terminology Criteria for Adverse Events; DCIS = ductal carcinoma in situ; EORTC = European Organisation … WebAug 26, 2024 · The Objective Breast Cosmesis Scale (OBCS) is an objective method that documents the aesthetic changes in breast cancer patients. This work evaluates the kOBCS © software ( http://www.kobcs.info) which simplifies the estimation of the OBCS values. Methods Five schematic drawings were photographed and imported into the kOBCS ©. harvey korman and tim conway